Engagements are structured around specific decision contexts: not open-ended retainers. Every tier delivers a defined instrument output with clear scope, timeline, and board-ready deliverables.
Entry is a sequence of decisions, each with a different exposure. Engagements are scoped to the moment you are actually in, and every one delivers a defined instrument output with clear scope, timeline, and board-ready deliverables. All engagements begin with a brief scoping conversation to confirm instrument fit.
One decision question, answered with a single instrument applied rigorously. For entrants and operators facing a defined choice with a deadline attached.
For investors and acquirers before capital is committed. Revenue assumptions stress-tested against how the Saudi payment system actually behaves, rather than how a business plan assumes it will.
For operators who have committed and are building out. Operational readiness for the payer environment assessed across the platforms, data obligations and processes that determine whether revenue arrives as modelled.
Two instruments sequenced deliberately, with a connecting strategic narrative that treats them as one decision rather than two reports. For organisations whose entry question spans both commitment and execution.
Every engagement follows the same structured process. The instrument changes; the rigour does not.
A brief call to confirm the decision context, identify the relevant instrument(s), and establish what a successful output looks like for your organisation.
The instrument is applied across defined dimensions. Responses are assessed against evidence criteria (Strong, Partial, or Weak. No guesswork. No generic scoring.)
Responses are synthesised into a structured risk profile. Failure modes, gaps, and exposure concentrations are surfaced and contextualised for your specific decision.
A structured written brief with your Proceed / Delay / Redesign recommendation and explicit conditions. The £4,000 diagnostics include a 60-minute executive briefing session.
HealthElevate's independence is its primary value. Our scope is deliberately bounded to protect it.
A full description of our independence model and conflict-of-interest framework is available on the About page.
Answers to the questions we hear most often before an engagement begins.
Management consultants advise on what to do and often stay to help you do it. HealthElevate advises on whether to proceed: before commitment, not after. We are not implementation partners. We provide pre-decision analytical assurance, then step away. This is a deliberate design choice, not a limitation.
Typically the decision owner (CFO, COO, Programme Director) and one or two subject-matter leads. We keep sessions small and focused. The output is written for board or executive committee presentation, even if the session itself is a small working group.
We work exclusively from publicly available data and information you choose to share with us. We do not require access to systems, patient data, or confidential commercial documents – though context you provide voluntarily will strengthen the diagnostic.
Yes. Instruments listed as available via bespoke engagement can be applied as part of a diagnostic or Entry Bundle engagement ahead of their public release. Please mention the specific instrument in your enquiry email.
Our primary focus is Saudi Arabia, the UAE, and the wider GCC, where our founder's operational expertise is deepest. We also work with UK-registered and internationally operating healthcare organisations where the decision context aligns with our instrument suite.
Send an email to contact@healthelevate.net describing your decision context and the tier you are interested in. We will respond within two working days to arrange a brief scoping conversation: at no charge – before any engagement is confirmed.
Every engagement starts with a brief scoping conversation: at no charge. Tell us about your decision context and we will identify the right instrument and tier.
Send an Enquiry